Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries

We are analyzing https://link.springer.com/article/10.1007/s00404-014-3389-z.

Title:
Anti-tumour activity of phosphoinositide-3-kinase antagonist AEZS-126 in models of ovarian cancer | Archives of Gynecology and Obstetrics
Description:
Purpose Platinum resistance is the most crucial problem for treatment of ovarian cancer. There is a clinical need for new treatment strategies which overcome platinum resistance. Recently high level of AKT was shown to be involved in platinum resistance and furthermore in resistance against Natural-killer (NK)-cell mediated killing in ovarian cancer. Methods Here, we investigate the ability of the PI3K/AKT inhibitor AEZS-126 alone and in combination with rapamycin to selectively target ovarian cancer cell proliferation and survival in vitro by MTT-assays and FACS based analysis. Furthermore the mechanism of cytotoxicity is analysed by FACS based assays. The NK-killing efficiency of ovarian cancer cells with and without pre-treatment with AEZS-126 was analysed. Results AEZS-126 showed good anti-tumour activity in in vitro models of ovarian cancer. Main mechanism of cytotoxicity seems to be necroptosis which could be abrogated by co-incubation with necrostatin-1. Furthermore pre-treatment of platinum resistant cells with AEZS-126 resulted in an increased accessibility of these tumour cells for killing by NK-cells. Conclusion We demonstrated the highly efficient anti-tumour activity of AEZS-126 in in vitro models of ovarian cancer. Due to the good anti-tumour activity and the expected increase in NK-cell mediated killing even of platinum resistant tumour cells, AEZS-126 seems to be a promising candidate for clinical testing in ovarian cancer.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Health & Fitness
  • Education
  • Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,626,432 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don't see any clear sign of profit-making.

Not all websites focus on profit; some are designed to educate, connect people, or share useful tools. People create websites for numerous reasons. And this could be one such example. Link.springer.com might be earning cash quietly, but we haven't detected the monetization method.

Keywords {🔍}

article, pubmed, cancer, google, scholar, cas, ovarian, cell, breast, central, platinum, cells, aezs, immunol, res, human, hahne, resistance, access, clin, antitumour, activity, models, meyer, akt, carcinoma, natural, killer, privacy, cookies, content, data, vitro, tumor, mol, information, publish, search, gynecology, kurz, honig, treatment, methods, target, mechanism, resistant, open, chemotherapy, targeted, pathway,

Topics {✒️}

month download article/chapter good anti-tumour activity pi3k/pten/akt/mtor pathways targeted therapies potential therapeutic target human nk-cell receptors newly diagnosed african-american nk-cell mediated killing triple-negative breast cancer phosphoinositide-3-kinase antagonist aezs-126 ovarian tumours—current data single-institution compilation compared pi3k/akt inhibitor aezs-126 pi3k/akt/mtor pathway lanier ll anti-tumour activity mtor signaling pathways full article pdf platinum resistant cells nk cell proliferation resistant ovarian cancers ovarian cancer cells chain-related molecule overcome platinum resistance overcoming platinum resistance cell mediated killing human ovarian carcinoma privacy choices/manage cookies human ovarian cancers epithelial ovarian cancer natural killer cells nk cell recognition related subjects therapy—implications end results database triple-negative/basal human breast tumours adjunct chemotherapy treatment basal breast cancer akt/pkb pathway article archives nk-killing efficiency cancer drug discovery national cancer institute pi3k pathway alterations pi3k pathway play caspase-specific inhibitors breast carcinoma characteristics suppressing tumor development shaping tumor immunogenicity

Questions {❓}

  • Moulder SL (2010) Does the PI3K pathway play a role in basal breast cancer?
  • Vivier E, Raulet DH, Moretta A et al (2011) Innate or adaptive immunity?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Anti-tumour activity of phosphoinositide-3-kinase antagonist AEZS-126 in models of ovarian cancer
         description:Platinum resistance is the most crucial problem for treatment of ovarian cancer. There is a clinical need for new treatment strategies which overcome platinum resistance. Recently high level of AKT was shown to be involved in platinum resistance and furthermore in resistance against Natural-killer (NK)-cell mediated killing in ovarian cancer. Here, we investigate the ability of the PI3K/AKT inhibitor AEZS-126 alone and in combination with rapamycin to selectively target ovarian cancer cell proliferation and survival in vitro by MTT-assays and FACS based analysis. Furthermore the mechanism of cytotoxicity is analysed by FACS based assays. The NK-killing efficiency of ovarian cancer cells with and without pre-treatment with AEZS-126 was analysed. AEZS-126 showed good anti-tumour activity in in vitro models of ovarian cancer. Main mechanism of cytotoxicity seems to be necroptosis which could be abrogated by co-incubation with necrostatin-1. Furthermore pre-treatment of platinum resistant cells with AEZS-126 resulted in an increased accessibility of these tumour cells for killing by NK-cells. We demonstrated the highly efficient anti-tumour activity of AEZS-126 in in vitro models of ovarian cancer. Due to the good anti-tumour activity and the expected increase in NK-cell mediated killing even of platinum resistant tumour cells, AEZS-126 seems to be a promising candidate for clinical testing in ovarian cancer.
         datePublished:2014-08-13T00:00:00Z
         dateModified:2014-08-13T00:00:00Z
         pageStart:131
         pageEnd:141
         sameAs:https://doi.org/10.1007/s00404-014-3389-z
         keywords:
            Ovarian cancer
            AKT
            Platinum-resistance
            NK-cells
            Gynecology
            Obstetrics/Perinatology/Midwifery
            Endocrinology
            Human Genetics
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00404-014-3389-z/MediaObjects/404_2014_3389_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00404-014-3389-z/MediaObjects/404_2014_3389_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00404-014-3389-z/MediaObjects/404_2014_3389_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00404-014-3389-z/MediaObjects/404_2014_3389_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00404-014-3389-z/MediaObjects/404_2014_3389_Fig5_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00404-014-3389-z/MediaObjects/404_2014_3389_Fig6_HTML.gif
         isPartOf:
            name:Archives of Gynecology and Obstetrics
            issn:
               1432-0711
               0932-0067
            volumeNumber:291
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Berlin Heidelberg
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Jens C. Hahne
               affiliation:
                     name:University Hospital of Würzburg
                     address:
                        name:Department of Gynecology, University Hospital of Würzburg, Würzburg, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Antje Kurz
               affiliation:
                     name:University Hospital of Würzburg
                     address:
                        name:Department of Gynecology, University Hospital of Würzburg, Würzburg, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Susanne R. Meyer
               affiliation:
                     name:University Hospital of Würzburg
                     address:
                        name:Department of Gynecology, University Hospital of Würzburg, Würzburg, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Johannes Dietl
               affiliation:
                     name:University Hospital of Würzburg
                     address:
                        name:Department of Gynecology, University Hospital of Würzburg, Würzburg, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jörg B. Engel
               affiliation:
                     name:University of Regensburg
                     address:
                        name:Department of Gynecology, University of Regensburg, Regensburg, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Arnd Honig
               affiliation:
                     name:University Hospital of Würzburg
                     address:
                        name:Department of Gynecology, University Hospital of Würzburg, Würzburg, Germany
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Anti-tumour activity of phosphoinositide-3-kinase antagonist AEZS-126 in models of ovarian cancer
      description:Platinum resistance is the most crucial problem for treatment of ovarian cancer. There is a clinical need for new treatment strategies which overcome platinum resistance. Recently high level of AKT was shown to be involved in platinum resistance and furthermore in resistance against Natural-killer (NK)-cell mediated killing in ovarian cancer. Here, we investigate the ability of the PI3K/AKT inhibitor AEZS-126 alone and in combination with rapamycin to selectively target ovarian cancer cell proliferation and survival in vitro by MTT-assays and FACS based analysis. Furthermore the mechanism of cytotoxicity is analysed by FACS based assays. The NK-killing efficiency of ovarian cancer cells with and without pre-treatment with AEZS-126 was analysed. AEZS-126 showed good anti-tumour activity in in vitro models of ovarian cancer. Main mechanism of cytotoxicity seems to be necroptosis which could be abrogated by co-incubation with necrostatin-1. Furthermore pre-treatment of platinum resistant cells with AEZS-126 resulted in an increased accessibility of these tumour cells for killing by NK-cells. We demonstrated the highly efficient anti-tumour activity of AEZS-126 in in vitro models of ovarian cancer. Due to the good anti-tumour activity and the expected increase in NK-cell mediated killing even of platinum resistant tumour cells, AEZS-126 seems to be a promising candidate for clinical testing in ovarian cancer.
      datePublished:2014-08-13T00:00:00Z
      dateModified:2014-08-13T00:00:00Z
      pageStart:131
      pageEnd:141
      sameAs:https://doi.org/10.1007/s00404-014-3389-z
      keywords:
         Ovarian cancer
         AKT
         Platinum-resistance
         NK-cells
         Gynecology
         Obstetrics/Perinatology/Midwifery
         Endocrinology
         Human Genetics
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00404-014-3389-z/MediaObjects/404_2014_3389_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00404-014-3389-z/MediaObjects/404_2014_3389_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00404-014-3389-z/MediaObjects/404_2014_3389_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00404-014-3389-z/MediaObjects/404_2014_3389_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00404-014-3389-z/MediaObjects/404_2014_3389_Fig5_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00404-014-3389-z/MediaObjects/404_2014_3389_Fig6_HTML.gif
      isPartOf:
         name:Archives of Gynecology and Obstetrics
         issn:
            1432-0711
            0932-0067
         volumeNumber:291
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Berlin Heidelberg
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Jens C. Hahne
            affiliation:
                  name:University Hospital of Würzburg
                  address:
                     name:Department of Gynecology, University Hospital of Würzburg, Würzburg, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Antje Kurz
            affiliation:
                  name:University Hospital of Würzburg
                  address:
                     name:Department of Gynecology, University Hospital of Würzburg, Würzburg, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Susanne R. Meyer
            affiliation:
                  name:University Hospital of Würzburg
                  address:
                     name:Department of Gynecology, University Hospital of Würzburg, Würzburg, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Johannes Dietl
            affiliation:
                  name:University Hospital of Würzburg
                  address:
                     name:Department of Gynecology, University Hospital of Würzburg, Würzburg, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jörg B. Engel
            affiliation:
                  name:University of Regensburg
                  address:
                     name:Department of Gynecology, University of Regensburg, Regensburg, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Arnd Honig
            affiliation:
                  name:University Hospital of Würzburg
                  address:
                     name:Department of Gynecology, University Hospital of Würzburg, Würzburg, Germany
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Archives of Gynecology and Obstetrics
      issn:
         1432-0711
         0932-0067
      volumeNumber:291
Organization:
      name:Springer Berlin Heidelberg
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University Hospital of Würzburg
      address:
         name:Department of Gynecology, University Hospital of Würzburg, Würzburg, Germany
         type:PostalAddress
      name:University Hospital of Würzburg
      address:
         name:Department of Gynecology, University Hospital of Würzburg, Würzburg, Germany
         type:PostalAddress
      name:University Hospital of Würzburg
      address:
         name:Department of Gynecology, University Hospital of Würzburg, Würzburg, Germany
         type:PostalAddress
      name:University Hospital of Würzburg
      address:
         name:Department of Gynecology, University Hospital of Würzburg, Würzburg, Germany
         type:PostalAddress
      name:University of Regensburg
      address:
         name:Department of Gynecology, University of Regensburg, Regensburg, Germany
         type:PostalAddress
      name:University Hospital of Würzburg
      address:
         name:Department of Gynecology, University Hospital of Würzburg, Würzburg, Germany
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Jens C. Hahne
      affiliation:
            name:University Hospital of Würzburg
            address:
               name:Department of Gynecology, University Hospital of Würzburg, Würzburg, Germany
               type:PostalAddress
            type:Organization
      name:Antje Kurz
      affiliation:
            name:University Hospital of Würzburg
            address:
               name:Department of Gynecology, University Hospital of Würzburg, Würzburg, Germany
               type:PostalAddress
            type:Organization
      name:Susanne R. Meyer
      affiliation:
            name:University Hospital of Würzburg
            address:
               name:Department of Gynecology, University Hospital of Würzburg, Würzburg, Germany
               type:PostalAddress
            type:Organization
      name:Johannes Dietl
      affiliation:
            name:University Hospital of Würzburg
            address:
               name:Department of Gynecology, University Hospital of Würzburg, Würzburg, Germany
               type:PostalAddress
            type:Organization
      name:Jörg B. Engel
      affiliation:
            name:University of Regensburg
            address:
               name:Department of Gynecology, University of Regensburg, Regensburg, Germany
               type:PostalAddress
            type:Organization
      name:Arnd Honig
      affiliation:
            name:University Hospital of Würzburg
            address:
               name:Department of Gynecology, University Hospital of Würzburg, Würzburg, Germany
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Gynecology, University Hospital of Würzburg, Würzburg, Germany
      name:Department of Gynecology, University Hospital of Würzburg, Würzburg, Germany
      name:Department of Gynecology, University Hospital of Würzburg, Würzburg, Germany
      name:Department of Gynecology, University Hospital of Würzburg, Würzburg, Germany
      name:Department of Gynecology, University of Regensburg, Regensburg, Germany
      name:Department of Gynecology, University Hospital of Würzburg, Würzburg, Germany
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(176)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

4.9s.